Prostate Cancer Clinical Trials in Denver

Showing 141-160 of 174 trials

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

NCT02080689

The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

Prostate Cancer

GenomeDx Biosciences Corp286 participantsStarted May 2014

Anchorage, Alaska, United States • Los Angeles, California, United States • Aurora, Colorado, United States +16 more locations

COMPLETEDPHASE3< 1 mile

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

NCT00003162

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases. PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases from breast or prostate cancer.

Breast CancerMetastatic CancerPain+1 more

Radiation Therapy Oncology Group949 participantsStarted Feb 1998

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Huntsville, Alabama, United States +250 more locations

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Prostate Cancer Trials in Other Cities

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy

Prostate Biomarker Study

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Multi-site Decision Impact Study for Decipher

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

Other Conditions in Denver